| 摘要 |
The present invention relates to a pharmaceutical composition for preventing or treating cancer comprising at least one selected from the group consisting of miR-28-5p, miR-323-5p, miR-510-5p, miR-552-3p, miR-608, and a mimetic thereof as an active ingredient. The miR-28-5p, miR-323-5p, miR-510-5p, miR-552-3p, miR-608, or a mimetic thereof of the present invention having effects in promoting apoptosis and inhibiting cell growth and, particularly, having cancer-specific effects, and having properties without effects on normal cells, can be broadly used for effective anticancer treatment without side effects. |
